Global Immune Checkpoint Inhibitors (ICI) Market Report 2020 Featuring FDA Approved Keytruda, Opdivo, Tecentriq, Imfinzi, Yervoy, Libtayo, and Bavencio

MLA

“Global Immune Checkpoint Inhibitors (ICI) Market Report 2020 Featuring FDA Approved Keytruda, Opdivo, Tecentriq, Imfinzi, Yervoy, Libtayo, and Bavencio.” Plus Company Updates, 17 Mar. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.617857228&authtype=sso&custid=ns315887.

APA

Global Immune Checkpoint Inhibitors (ICI) Market Report 2020 Featuring FDA Approved Keytruda, Opdivo, Tecentriq, Imfinzi, Yervoy, Libtayo, and Bavencio. (2020, March 17). Plus Company Updates.

Chicago

Plus Company Updates. 2020. “Global Immune Checkpoint Inhibitors (ICI) Market Report 2020 Featuring FDA Approved Keytruda, Opdivo, Tecentriq, Imfinzi, Yervoy, Libtayo, and Bavencio,” March 17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.617857228&authtype=sso&custid=ns315887.